Michael Edward L.
Known title: DirectorCIK: 0001391823
Associated companies
Transaction History
| QDEL | ▲ Buy | Grant | 963 | $0 | 6/6/2026 | View on chart |
| QDEL | ▲ Buy | Grant | 289 | $0 | 6/6/2026 | View on chart |
| QDEL | ▲ Buy | Grant | 6,829 | $0 | 5/29/2026 | View on chart |
| QDEL | ▲ Buy | Grant | 4,929 | $0 | 5/22/2025 | View on chart |
| QDEL | ▲ Buy | Grant | 555 | $0 | 5/18/2025 | View on chart |
| QDEL | ▲ Buy | Grant | 166 | $0 | 5/18/2025 | View on chart |
| QDEL | ▲ Buy | Grant | 2,416 | $0 | 5/24/2024 | View on chart |
| QDEL | ▲ Buy | Grant | 356 | $0 | 5/12/2024 | View on chart |
| QDEL | ▲ Buy | Grant | 106 | $0 | 5/12/2024 | View on chart |
| QDEL | ▲ Buy | Grant | 2,248 | $0 | 6/6/2023 | View on chart |
| QDEL | ▲ Buy | Grant | 1,137 | $0 | 5/14/2023 | View on chart |
| QDEL | ▲ Buy | Grant | 341 | $0 | 5/14/2023 | View on chart |
| QDEL | ▲ Buy | Grant | 9,098 | — | 5/27/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
QuidelOrtho Reports Q2 2026 Results and New IR Lead
QuidelOrtho released its second-quarter 2026 earnings, with reports noting that profit margins have recovered while cash levels remain a point of discussion. The company also announced the appointment of Sanjeev Sharma as Vice President of Investor Relations. These updates provide context for the stock's current position within its 52-week range.
QuidelOrtho Reports Q2 2026 Results and New IR Lead. QuidelOrtho released its second-quarter 2026 earnings, with reports noting that profit margins have recovered while cash levels remain a point of discussion. The company also announced the appointment of Sanjeev Sharma as Vice President of Investor Relations. These updates provide context for the stock's current position within its 52-week range.